CENTURI HOLDINGS INC (CTRI)

US1559231055 - Common Stock

26.77  +0.83 (+3.2%)

Fundamental Rating

1

CTRI gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 43 industry peers in the Construction & Engineering industry. Both the profitability and financial health of CTRI have multiple concerns. CTRI is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

CTRI had negative earnings in the past year.

1.2 Ratios

CTRI's Return On Assets of -8.78% is on the low side compared to the rest of the industry. CTRI is outperformed by 81.40% of its industry peers.
CTRI has a Return On Equity of -94.14%. This is amonst the worse of the industry: CTRI underperforms 81.40% of its industry peers.
With a decent Return On Invested Capital value of 6.39%, CTRI is doing good in the industry, outperforming 62.79% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CTRI is below the industry average of 8.44%.
The last Return On Invested Capital (6.39%) for CTRI is above the 3 year average (4.00%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -8.78%
ROE -94.14%
ROIC 6.39%
ROA(3y)-4.59%
ROA(5y)N/A
ROE(3y)-39.14%
ROE(5y)N/A
ROIC(3y)4%
ROIC(5y)N/A

1.3 Margins

CTRI's Operating Margin of 4.71% is in line compared to the rest of the industry. CTRI outperforms 46.51% of its industry peers.
CTRI has a Gross Margin of 9.43%. This is in the lower half of the industry: CTRI underperforms 72.09% of its industry peers.
Industry RankSector Rank
OM 4.71%
PM (TTM) N/A
GM 9.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

CTRI has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, CTRI has a worse debt to assets ratio.

2.2 Solvency

CTRI has an Altman-Z score of 2.31. This is not the best score and indicates that CTRI is in the grey zone with still only limited risk for bankruptcy at the moment.
CTRI's Altman-Z score of 2.31 is in line compared to the rest of the industry. CTRI outperforms 41.86% of its industry peers.
CTRI has a Debt/Equity ratio of 5.95. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CTRI (5.95) is worse than 83.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.95
Debt/FCF N/A
Altman-Z 2.31
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

CTRI has a Current Ratio of 1.39. This is a normal value and indicates that CTRI is financially healthy and should not expect problems in meeting its short term obligations.
CTRI has a Current ratio of 1.39. This is in the better half of the industry: CTRI outperforms 60.47% of its industry peers.
CTRI has a Quick Ratio of 1.39. This is a normal value and indicates that CTRI is financially healthy and should not expect problems in meeting its short term obligations.
CTRI has a Quick ratio of 1.39. This is in the better half of the industry: CTRI outperforms 65.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 1.39

0

3. Growth

3.1 Past

The earnings per share for CTRI have decreased strongly by -10.72% in the last year.
The Revenue has been growing slightly by 5.03% in the past year.
EPS 1Y (TTM)-10.72%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2QN/A
Revenue 1Y (TTM)5.03%
Revenue growth 3YN/A
Revenue growth 5YN/A
Revenue growth Q2QN/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

1

4. Valuation

4.1 Price/Earnings Ratio

CTRI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

CTRI's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CTRI is cheaper than 72.09% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.68

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CTRI!.
Industry RankSector Rank
Dividend Yield N/A

CENTURI HOLDINGS INC

NYSE:CTRI (5/17/2024, 7:04:01 PM)

26.77

+0.83 (+3.2%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.37B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.78%
ROE -94.14%
ROCE
ROIC
ROICexc
ROICexgc
OM 4.71%
PM (TTM) N/A
GM 9.43%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 5.95
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.39
Quick Ratio 1.39
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-10.72%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5.03%
Revenue growth 3YN/A
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y